May 27, 2025

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Exploring a 13.57% Potential Upside in the Healthcare Sector

Aveanna Healthcare Holdings Inc (AVAH), a prominent player in the U.S. healthcare sector, operates a diversified home care platform that focuses on delivering patient-centered services. With..

Phreesia, Inc. (PHR) Stock Analysis: 32% Potential Upside Amid Strong Revenue Growth

Phreesia, Inc. (PHR), a healthcare technology company that provides a comprehensive SaaS-based platform for patient intake and payments, has caught the attention of investors with its..

Azenta, Inc. (AZTA) Investor Outlook: Unpacking the 54% Potential Upside

Azenta, Inc. (NASDAQ: AZTA), a key player in the healthcare sector specializing in medical instruments and supplies, presents a compelling opportunity for investors, particularly given its..

Artivion, Inc. (AORT) Stock Analysis: Promising 13% Upside Potential Amid Healthcare Innovations

Artivion, Inc. (NASDAQ: AORT) is making waves in the healthcare sector with its innovative approach to medical devices and implantable human tissues. With a market capitalization..

Addus HomeCare Corporation (ADUS): Investor Outlook with a Promising 21% Upside

Addus HomeCare Corporation (NASDAQ: ADUS), a significant player in the healthcare sector, primarily operates within the medical care facilities industry. With a market cap of $2.06..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a 216.80% Potential Upside for Investors

Opko Health, Inc. (NASDAQ: OPK) presents a compelling opportunity for investors looking to dive into the dynamic healthcare sector, specifically within diagnostics and pharmaceuticals. Headquartered in..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: A Promising Biotech with 139.73% Upside Potential

Ocular Therapeutix, Inc. (OCUL), a Massachusetts-based biopharmaceutical company specializing in innovative treatments for eye conditions, is increasingly capturing the attention of investors. With a market capitalization..

CRISPR Therapeutics AG (CRSP) Stock Analysis: 122% Potential Upside Beckons Investors

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneering entity in the biotechnology landscape, has captured investor attention with its cutting-edge CRISPR/Cas9 gene-editing technology. Based in Zug, Switzerland,..

Amphastar Pharmaceuticals (AMPH) Stock Analysis: Exploring a 32.41% Potential Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) stands as a dynamic player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market..

Clover Health Investments (CLOV) Stock Analysis: A 46.94% Upside Potential in Healthcare Plans

Clover Health Investments, Corp (NASDAQ: CLOV) has been making waves in the healthcare plans sector, particularly with its innovative approach to Medicare Advantage plans. Headquartered in..

89bio, Inc. (ETNB) Stock Analysis: Exploring the 210% Upside Potential in Biotech

89bio, Inc. (NASDAQ: ETNB), a clinical-stage biopharmaceutical company, is capturing investor attention with its impressive potential upside of over 210%. Focused on pioneering treatments for liver..

Liquidia Corporation (LQDA): Analyst Consensus Points to a 74.59% Upside Potential

Liquidia Corporation (NASDAQ: LQDA) has recently captured the attention of investors, given its substantial upside potential. With a market capitalization of $1.31 billion, this U.S.-based biopharmaceutical..

LivaNova PLC (LIVN) Stock Analysis: Navigating a 46% Potential Upside Amidst Healthcare Innovations

LivaNova PLC (NASDAQ: LIVN) finds itself at an intriguing juncture that beckons attention from savvy investors. With a market capitalization of $2.28 billion, this United Kingdom-based..

Viridian Therapeutics, Inc. (VRDN): Analyst Ratings Highlight 182% Potential Upside

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a prominent player in the biotechnology industry, is capturing investor attention with its promising pipeline and strong analyst support. With a..

Ardent Health Partners, Inc. (ARDT) Stock Analysis: Exploring a 38.98% Potential Upside

Ardent Health Partners, Inc. (ARDT), a key player in the healthcare sector, operates a comprehensive network of hospitals and clinics across the United States. With a..

Alvotech (ALVO) Stock Analysis: Unveiling a 75% Potential Upside in the Biosimilar Market

Alvotech (NASDAQ: ALVO), a prominent player in the healthcare sector specializing in the development and manufacturing of biosimilar medicines, is capturing investor attention with a noteworthy..

Immunovant, Inc. (IMVT) Stock Analysis: Biotech with a Potential 212% Upside

Immunovant, Inc. (NASDAQ: IMVT), a clinical-stage biopharmaceutical company, has been capturing the attention of investors with its promising pipeline and potential for significant upside. Focused on..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Exploring a Potential 137.5% Upside

Dynavax Technologies Corporation (NASDAQ: DVAX), a key player in the healthcare sector, is making waves in the biopharmaceutical landscape with its innovative vaccine solutions. As a..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Unpacking a 69.79% Potential Upside

GoodRx Holdings, Inc. (GDRX), a key player in the healthcare sector, presents an intriguing opportunity for investors interested in the health information services industry. With a..

Kestra Medical Technologies (KMTS) Stock Analysis: Unveiling a Potential 23.93% Upside in the Healthcare Sector

Kestra Medical Technologies, Ltd. (KMTS), a rising star in the healthcare sector, is turning heads with its impressive revenue growth and a compelling potential upside of..

Search

Funds

May 27, 2025

Search

Funds

May 27, 2025

FTSE 100

Funds